TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00813930 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04418908 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01463605 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02829580 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03359096 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02332486 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02332486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00582777 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00582777 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01430494 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT02413489 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05253599 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05253599 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03046576 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01750567 — Predictive Biomarker (PRD): INSR mRNA
Genes: INSR
Study NCT01750567 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT02901847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04465513 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04649463 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01488994 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study NCT03391479 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03354676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00840931 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00840931 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00005949 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01286077 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03181490 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02191332 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03989817 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT05274945 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01745263 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01745263 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01808313 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00054535 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05685810 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT05685810 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT01388387 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00219011 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00208455 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03694977 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03694977 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03694977 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03694977 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT03694977 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03034824 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03034824 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01520727 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00515021 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT02008383 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02008383 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00455897 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00232531 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02630407 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03130582 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03130582 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02948179 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT02948179 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study NCT01758575 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00157027 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00462605 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02133846 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT02574325 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02531854 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02531854 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01743820 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT01867047 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02559908 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05106582 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT01090011 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04578288 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02807974 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02807974 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03957018 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02568696 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT03321851 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02777255 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT01999972 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01999972 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01999972 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT01999972 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01999972 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00009906 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study NCT00612560 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01290367 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03548467 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT00178490 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02078115 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03207529 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03207529 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02186860 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03055169 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study NCT03683537 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT01965067 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00686400 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01575340 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03961594 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT00123227 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00590564 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT04137458 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT03182517 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03593083 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03593083 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03047616 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03047616 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02974049 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03693053 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01211314 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05276271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05276271 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05276271 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02907333 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01054729 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT03393949 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03246659 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT04530500 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01242488 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01518205 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03913364 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04395170 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01391104 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01391104 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01808131 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00455195 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT04475601 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT06241365 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04789005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01762969 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01762969 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02065479 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01373086 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02312375 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02097186 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00497666 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02481778 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study NCT00676845 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00824330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02392754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01098448 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03789422 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02349945 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02884037 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03321981 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03321981 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03321981 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01038453 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03178591 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03178591 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03178591 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02729467 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02729467 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study NCT01642108 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01642108 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03704909 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00348309 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02418325 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03023891 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02579993 — Predictive Biomarker (PRD): ABCB5 mRNA
Genes: ABCB5
Study NCT02480647 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT04577131 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04618354 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02994511 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00127959 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02134912 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04142268 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01228162 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03797534 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT03797534 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00155701 — Predictive Biomarker (PRD): DISC1 mRNA
Genes: DISC1; KIAA0457
Study NCT02481245 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04688177 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00775411 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00775411 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00775411 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02361086 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT01035853 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04200144 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03002558 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04539717 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00621205 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT01242527 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02522988 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01682291 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00244647 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT01005875 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT03312075 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT03087266 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04331600 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01472952 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01069783 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00195702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00992992 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00759642 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00759642 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00759642 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05063682 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02416466 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04504045 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04504045 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT04504045 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT04504045 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT04504045 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04504045 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04504045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04504045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02698917 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT04224961 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT04542863 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04542863 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01609881 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT01609881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01833572 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00458276 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03895710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02461121 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02167828 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04434040 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02001727 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03495999 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03495999 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03495999 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00795301 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01386775 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT00970229 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT03839238 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02855905 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03766945 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study NCT00841581 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00276835 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00276835 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03689816 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04606940 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02706535 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01682837 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01204190 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01600989 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01600989 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01600989 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT04008251 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00033891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04166097 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04333628 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT01734512 — Predictive Biomarker (PRD): PNOC mRNA
Genes: PNOC; OFQ
Study NCT02266628 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00148876 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03345745 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study NCT03345745 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00405938 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00405938 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01649284 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00959023 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT01162265 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00089466 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05262153 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT05262153 — Predictive Biomarker (PRD): IL34 mRNA
Genes: IL34; C16orf77
Study NCT04623606 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06029335 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT06029335 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02908750 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02908750 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01246089 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02633436 — Predictive Biomarker (PRD): SLC1A5 mRNA
Genes: SLC1A5; ASCT2; M7V1; RDR; RDRC
Study NCT02051257 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02051257 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28